Correlation Between Atea Pharmaceuticals and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Black Diamond Therapeutics, you can compare the effects of market volatilities on Atea Pharmaceuticals and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Black Diamond.
Diversification Opportunities for Atea Pharmaceuticals and Black Diamond
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Atea and Black is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Black Diamond go up and down completely randomly.
Pair Corralation between Atea Pharmaceuticals and Black Diamond
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the Black Diamond. But the stock apears to be less risky and, when comparing its historical volatility, Atea Pharmaceuticals is 2.69 times less risky than Black Diamond. The stock trades about -0.26 of its potential returns per unit of risk. The Black Diamond Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 214.00 in Black Diamond Therapeutics on November 3, 2024 and sell it today you would earn a total of 48.00 from holding Black Diamond Therapeutics or generate 22.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atea Pharmaceuticals vs. Black Diamond Therapeutics
Performance |
| Timeline |
| Atea Pharmaceuticals |
| Black Diamond Therap |
Atea Pharmaceuticals and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atea Pharmaceuticals and Black Diamond
The main advantage of trading using opposite Atea Pharmaceuticals and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |